07/23/2024
Big patent and team news today: our 3rd US patent on DIBI issued this month and Dr. Trisha Ang joined our team as VP of Research and Development. She is very experienced with DIBI having synthesized it and leading the manufacturing process optimization and being a co-inventor on this and other DIBI patents.
July 23, 2024, Redwood City, CA, USA – Fe Pharmaceuticals, a pioneering biotech company focused on innovative treatments for infectious diseases, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,024,490, titled "Polymeric Metal Chelati...
